3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 30.65
-0.35 (-1.13%)
May 8, 2026, 1:48 PM CST
3D Global Biotech Revenue
In the year 2025, 3D Global Biotech had annual revenue of 206.74M TWD, down -22.19%. 3D Global Biotech had revenue of 103.89M in the half year ending December 31, 2025, with 804.58% growth.
Revenue
206.74M
Revenue Growth
-22.19%
P/S Ratio
11.58
Revenue / Employee
n/a
Employees
43
Market Cap
2.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 206.74M | -58.95M | -22.19% |
| Dec 31, 2024 | 265.69M | 245.05M | 1,187.68% |
| Dec 31, 2023 | 20.63M | 6.99M | 51.24% |
| Dec 31, 2022 | 13.64M | 2.57M | 23.19% |
| Dec 31, 2021 | 11.08M | -2.19M | -16.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.07B |
| Apex Biotechnology | 1.94B |
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| Genomics BioSci & Tech. | 708.38M |
| G&E Herbal Biotechnology | 309.13M |
| HeXun Biosciences | 293.23M |
| Sunny Pharmtech | 253.01M |
| Gwo Xi Stem Cell Applied Technology Co. , | 187.02M |